-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Ionis Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $32M, a 23.2% increase year-over-year.
- Ionis Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $120M, a 14.5% increase year-over-year.
- Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $106M, a 5.53% increase from 2022.
- Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $100M, a 16.9% decline from 2021.
- Ionis Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $121M, a 47.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)